Jeffrey Alan Wolf insider trades

Open-market stock purchases and sales by Jeffrey Alan Wolf, Director at Theriva Biologics, Inc, from SEC Form 4 filings since Dec 22, 2009.

Recent trades

DateStockTradeValue
Jan 5, 2026TOVX Theriva Biologics, IncBought (not open market)—

Companies traded

  • TOVX Theriva Biologics, Inc: other filings, last Jan 5, 2026
  • SCPX Scorpius Holdings, Inc: other filings, last May 16, 2024
  • NHWK NightHawk Biosciences, Inc: other filings, last Dec 7, 2022
  • HTBX Heat Biologics, Inc: 4 buys, last Dec 30, 2021
  • SYN Synthetic Biologics, Inc: other filings, last Dec 23, 2021
  • AEN Adeona Pharmaceuticals, Inc: other filings, last Jan 5, 2011

Get free alerts when Jeffrey Alan Wolf files a new trade →